Registered outcomes31

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 20 of 31

List	Outcome	Time frame	Description
Primary	Feasibility - Recruitment duration	Ongoing during the study recruitment period.	Total number of days taken to recruit participants.
Primary	Feasibility - Recruitment methods	Ongoing during the study recruitment period.	All methods (types/sources) used to recruit participants.
Primary	Feasibility - Recruitment screening time	Ongoing during the study recruitment period.	Time spent screening each participant (minutes).
Primary	Feasibility - Recruitment eligibility rate	Ongoing during the study recruitment period.	Percentage of screened individuals who were eligible for study participation.
Primary	Feasibility - Recruitment exclusion reasons	Ongoing during the study recruitment period.	Frequency of exclusion criteria recorded during eligibility screening.
Primary	Feasibility - Adherence	Ongoing during the 12-week intervention.	Total number of sessions attended out of a possible 24.
Primary	Feasibility - Compliance frequency	Ongoing during the 12-week intervention.	Extent to which each participant followed the prescribed exercise protocol in terms of frequency (sessions/week).
Primary	Feasibility - Compliance duration	Ongoing during the 12-week intervention.	Extent to which each participant followed the prescribed exercise protocol in terms of duration (minutes/session).
Primary	Feasibility - Compliance intensity	Ongoing during the 12-week intervention.	Extent to which each participant followed the prescribed exercise protocol in terms of intensity.
Primary	Feasibility - Attrition frequency	Over the course of the 24-week study period.	Total number of participants who dropped out of the study before completion.
Primary	Feasibility - Attrition reasons	Over the course of the 24-week study period.	Reasons for participant dropout (if applicable).
Primary	Feasibility - Time required for testing sessions	At each testing timepoint (Baseline, 6, 12, and 24 weeks).	Total time spent collecting, entering, checking, and processing outcome data per testing time point.
Primary	Feasibility - Time required for training sessions	Ongoing during the 12-week intervention.	Total time spent collecting, entering and checking training data per training session.
Primary	Feasibility - Personnel required	Over the course of the 24-week study period.	Ratio of participants to personnel (researchers) per testing and training session.
Primary	Feasibility - Personnel training completed	Before delivery of the 12-week intervention.	Number and type of training activities completed by study personnel before starting the intervention.
Primary	Feasibility - Time required for research ethics approval	Before the start of the trial.	Time taken from submission to full approval of study protocol.
Primary	Feasibility - Adverse events	Over the course of the 24-week study period (recorded at each testing and training session).	Number, type, and timing of adverse events.
Primary	Feasibility - Acceptability of equipment	After the 12-week intervention.	Participant feedback on equipment enjoyment, confidence in equipment use, perceived fitness benefits of the equipment, and recommendations and expected use of the equipment in community exercise settings.
Primary	Feasibility - Acceptability of outcomes	At each testing timepoint (Baseline, 6, 12 and 24 weeks).	Assessor feedback on what went well during outcome testing, specific challenges encountered, the timing of outcome delivery, and suggestions for improvement.
Secondary	Cardiorespiratory fitness	Baseline and 12 weeks	Peak volume of oxygen uptake (VO2peak) achieved during a cardiopulmonary exercise test on a recumbent stepper

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07546721/registered

API reference For AI assistants

Registered outcomes31

Sources 3

Read this list from software.